Delivery Order SPE2DB20D1051-SPE2DB24FD8DG
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,031.10 firm fixed price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% 5ml, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to deliver a...
- This federal contract award is for the delivery of 4566504595 - BRIMONIDINE TARTRATE 0.15% DRP 10ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,500.60 firm fixed-price delivery order contract has a completion date of November 21, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $2,773.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561935300 BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for the branded ophthalmic solution and runs from August 24 through August 25, 2023. As a top pharmaceutical supplier, Amerisourcebergen will deliver the requested medications to the DLA, the Department of...
- This federal contract award is for the delivery of Brimonidine Tartrate 0.1% eye drops in a 5mL volume. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $1,170.00 and a completion date of November 7, 2024. The awardee is not subject to any set-aside requirements. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,022.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.1% eye drops, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award is for the delivery of brimonidine tartrate 0.15% eye drops with a ceiling value of $2,654.64. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,550.57 firm fixed-price delivery order is for the supply of 30-gram tubes of 0.33% brimonidine gel, a medication used to treat glaucoma. The contract has an ultimate completion date of July 9, 2024. Amerisourcebergen is the prime contractor and does not have any major subcontractors listed. This...
- This contract award, with ID SPE2DB20D3103|SPE2DB23FM6W3, is for the delivery of Brimonidine Tartrate 0.15% ophthalmic drops in 15ml bottles to the Defense Logistics Agency (DLA). The $6,753.71 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on March 7, 2023 with a completion date of March 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.64 to AmerisourceBergen Drug Corp for the supply of Brimonidine Tartrate 0.15% ophthalmic drops (10 mL) on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is a child...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD8DGDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,881.86 Firm Fixed Price Delivery Order is for the supply of 4564713029 - BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 5/24/24 |